We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.36%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$657M
AUM Growth
+$275M
(+72%)
Cap. Flow
+$250M
Cap. Flow
% of AUM
38.11%
Top 10 Holdings %
Top 10 Hldgs %
46.95%
Holding
2,266
New
348
Increased
793
Reduced
382
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$29.7M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$15.3M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$10.7M |
| 4 |
Apple
AAPL
|
+$10.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.92M |
| 2 |
Advanced Micro Devices
AMD
|
+$470K |
| 3 |
Mission Produce
AVO
|
+$456K |
| 4 |
Ovintiv
OVV
|
+$272K |
| 5 |
ResMed
RMD
|
+$169K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14% |
| 2 | Technology | 12.89% |
| 3 | Consumer Discretionary | 4.89% |
| 4 | Healthcare | 4.71% |
| 5 | Communication Services | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Novartis
NVS
$297B
| $546K | 0.08% |
6,247
+1,684
| +37% | +$140K |
|
152
Netflix
NFLX
$309B
| $539K | 0.08% |
8,950
+270
| +3% | +$17.3K |
|
153
Thermo Fisher Scientific
TMO
$220B
| $538K | 0.08% |
806
+206
| +34% | +$129K |
|
154
Moderna
MRNA
$23.6B
| $537K | 0.08% |
2,114
+1,698
| +408% | +$496K |
|
155
Western Midstream Partners
WES
$19.3B
| $537K | 0.08% |
+24,092
| New | +$515K |
|
156
3M
MMM
$94.3B
| $528K | 0.08% |
3,555
+1,393
| +64% | +$208K |
|
157
US Global Jets ETF
JETS
$800M
| $527K | 0.08% |
+25,000
| New | +$558K |
|
158
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $525K | 0.08% |
5,649
+5,609
| +14,023% | +$506K |
|
159
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $524K | 0.08% |
9,727
| – | – |
|
|
BLE
160
DELISTED
BlackRock Municipal Income Trust II
BLE
| $519K | 0.08% |
+34,300
| New | +$522K |
|
|
HIX
161
Western Asset High Income Fund II
HIX
$355M
| $516K | 0.08% |
+72,105
| New | +$512K |
|
162
Illinois Tool Works
ITW
$84.5B
| $515K | 0.08% |
2,085
+1,531
| +276% | +$356K |
|
163
iShares Russell Mid-Cap ETF
IWR
$57.4B
| $515K | 0.08% |
+6,199
| New | +$509K |
|
164
TC Energy
TRP
$65.9B
| $512K | 0.08% |
10,998
+9,602
| +688% | +$475K |
|
165
Gilead Sciences
GILD
$165B
| $506K | 0.08% |
6,967
+34
| +0.5% | +$2.34K |
|
166
Boston Scientific
BSX
$71.5B
| $499K | 0.08% |
11,739
+80
| +0.7% | +$3.36K |
|
167
iShares Russell 2000 Value ETF
IWN
$14.6B
| $499K | 0.08% |
+3,007
| New | +$501K |
|
168
Cincinnati Financial
CINF
$27.1B
| $497K | 0.08% |
4,361
+4,146
| +1,928% | +$490K |
|
169
Union Pacific
UNP
$174B
| $496K | 0.08% |
1,967
+434
| +28% | +$103K |
|
|
170
Mission Produce
AVO
$1.17B
| $485K | 0.07% |
30,900
-24,500
| -44% | -$456K |
|
171
Invesco Municipal Opportunity Trust
VMO
$663M
| $483K | 0.07% |
+35,000
| New | +$475K |
|
172
Honeywell
HON
$78B
| $477K | 0.07% |
2,428
+1,016
| +72% | +$205K |
|
173
Starwood Property Trust
STWD
$6.09B
| $476K | 0.07% |
19,573
+19,449
| +15,685% | +$490K |
|
174
Otis Worldwide
OTIS
$28.2B
| $464K | 0.07% |
5,328
+4,035
| +312% | +$338K |
|
175
Amgen
AMGN
$222B
| $455K | 0.07% |
2,021
+291
| +17% | +$61.4K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Lindbrook Capital held 2,266 positions worth $657M, up 72% from $382M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Lindbrook Capital deployed $250M of net new capital in Q4 2021, opening 348 new positions and adding to 793 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $1.92M trimmed.
- Lindbrook Capital's largest Q4 2021 buy was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.
- Lindbrook Capital added most to iShares Russell 1000 Growth ETF in Q4 2021, an estimated $29.7M increase.
- Lindbrook Capital's biggest Q4 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.92M.
- Lindbrook Capital fully exited iShares MSCI South Korea ETF in Q4 2021, selling an estimated $93K.
- Lindbrook Capital's ten largest holdings make up 47% of its $657M portfolio in Q4 2021.
- Lindbrook Capital opened 348 new positions and closed 125 in Q4 2021.
- Lindbrook Capital's portfolio value rose 72% quarter-over-quarter to $657M.
Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.